{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:29:12Z","timestamp":1791084552257,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Roche Diagnostics International Ltd, Rotkreuz, Switzerland"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women. Current international PCOS assessment and management guidelines recommend anti-M\u00fcllerian hormone (AMH) as an alternative to transvaginal ultrasound for assessing polycystic ovarian morphology, which is one of three criteria for diagnosing PCOS. This study assessed the economic impact of using the Elecsys\u00ae AMH Plus immunoassay (Roche Diagnostics International Ltd, Rotkreuz, Switzerland) for AMH testing in the United Kingdom health system to assess women with signs and symptoms of PCOS. A decision tree model estimated the costs and health outcomes of using the Elecsys AMH Plus immunoassay to determine polycystic ovarian morphology as part of PCOS assessment in a simulated cohort of women aged 25\u201345 years who were exposed to different diagnosis pathways. The comparator scenario was the standard of care, where transvaginal ultrasound was used for assessment. Base-case results indicated that the Elecsys AMH Plus immunoassay could lead to cost savings of \u00a3284,029 per year on the total cost of PCOS diagnosis (1.4% reduction vs. transvaginal ultrasound), in addition to savings on managing secondary comorbidities, such as type 2 diabetes and stroke care. Cost savings with the Elecsys AMH Plus immunoassay were observed in all scenarios versus using transvaginal ultrasound, including scenarios with various referral rates to specialists and dropout rates from the diagnosis pathway, and low adherence to lifestyle recommendations. With the known current delays in the United Kingdom for diagnosis of PCOS, implementing the Elecsys AMH Plus immunoassay for AMH testing may not only provide cost benefits, but also reduce waiting times for diagnosis and treatment, improving patient health outcomes.<\/jats:p>","DOI":"10.1371\/journal.pone.0326162","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:32:40Z","timestamp":1750167160000},"page":"e0326162","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Economic impact of the Elecsys anti-M\u00fcllerian hormone Plus immunoassay for anti-M\u00fcllerian hormone testing as part of polycystic ovary syndrome assessment in the United Kingdom"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-4247","authenticated-orcid":true,"given":"Osvaldo Ulises","family":"Garay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Olziersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop","family":"Laven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6377-6197","authenticated-orcid":true,"given":"Rebecca","family":"Mawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Sillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"1","key":"pone.0326162.ref001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"E Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"pone.0326162.ref002","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"S Siddiqui","year":"2022","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"pone.0326162.ref003","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"BO Yildiz","year":"2012","journal-title":"Hum Reprod"},{"issue":"4","key":"pone.0326162.ref004","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/healthcare11040562","article-title":"Study of burden in polycystic ovary syndrome at global, regional, and national levels from 1990 to 2019","volume":"11","author":"Y Gao","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"pone.0326162.ref005","first-page":"104074","article-title":"Probable discrepancy in the prevalence of polycystic ovarian syndrome (PCOS)","volume":"79","author":"H Javed","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"pone.0326162.ref006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7570\/jomes21043","article-title":"Unravelling polycystic ovary syndrome and its comorbidities","volume":"30","author":"K-W Kim","year":"2021","journal-title":"J Obes Metab Syndr"},{"issue":"6","key":"pone.0326162.ref007","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cen.13828","article-title":"Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews","volume":"89","author":"EW Gilbert","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"pone.0326162.ref008","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"V Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"6","key":"pone.0326162.ref009","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ejendo\/lvae057","article-title":"Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data","volume":"190","author":"L Kujanp\u00e4\u00e4","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"pone.0326162.ref010","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/aogs.14382","article-title":"Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: a population-based cohort study","volume":"101","author":"L Kujanp\u00e4\u00e4","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"pone.0326162.ref011","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2016-3863","article-title":"Psychological distress is more prevalent in fertile age and premenopausal women with PCOS symptoms: 15-year follow-up","volume":"102","author":"S Karjula","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0326162.ref012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","article-title":"Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study","volume":"189","author":"M-M Ollila","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"pone.0326162.ref013","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences","volume":"107","author":"C Riestenberg","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0326162.ref014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajum.12096","article-title":"Rotterdam criteria, the end","volume":"21","author":"M-E Smet","year":"2018","journal-title":"Australas J Ultrasound Med"},{"issue":"6","key":"pone.0326162.ref015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"JP Christ","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"pone.0326162.ref016","author":"National Institute for Health and Care Excellence (NICE)","year":"2024"},{"issue":"3","key":"pone.0326162.ref017","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1373\/clinchem.2017.284331","article-title":"Challenges in the assessment and diagnosis of polycystic ovary syndrome","volume":"65","author":"JR Wiencek","year":"2019","journal-title":"Clin Chem"},{"issue":"2","key":"pone.0326162.ref018","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"M Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"pone.0326162.ref019","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.fertnstert.2021.05.094","article-title":"Antim\u00fcllerian hormone to determine polycystic ovarian morphology","volume":"116","author":"A Dietz de Loos","year":"2021","journal-title":"Fertil Steril"},{"key":"pone.0326162.ref020","volume-title":"Transvaginal ultrasound examinations \u2013 guidance for practitioners","author":"British Medical Ultrasound Society","year":"2022"},{"key":"pone.0326162.ref021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1757-2215-2-6","article-title":"Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement","volume":"2","author":"ME Lujan","year":"2009","journal-title":"J Ovarian Res"},{"issue":"670","key":"pone.0326162.ref022","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3399\/bjgp18X696101","article-title":"Polycystic ovarian syndrome: an under-recognised problem?","volume":"68","author":"SC Hillman","year":"2018","journal-title":"Br J Gen Pract"},{"issue":"10","key":"pone.0326162.ref023","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International Evidence-based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"HJ Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0326162.ref024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bpobgyn.2016.03.004","article-title":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome","volume":"37","author":"P Bhide","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"pone.0326162.ref025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/ejendo\/lvad065","article-title":"AMH as part of the diagnostic PCOS workup in large epidemiological studies","volume":"188","author":"TT Piltonen","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"pone.0326162.ref026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"D Husereau","year":"2022","journal-title":"Value Health"},{"issue":"4","key":"pone.0326162.ref027","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","article-title":"Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017","volume":"36","author":"J Liu","year":"2021","journal-title":"Hum Reprod"},{"key":"pone.0326162.ref028","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-10-96","article-title":"Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare","volume":"10","author":"L Gabrielli","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"pone.0326162.ref029","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"D Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"pone.0326162.ref030","author":"Office for National Statistics","year":"2021"},{"key":"pone.0326162.ref031","doi-asserted-by":"crossref","DOI":"10.2196\/48854","article-title":"Validation of an anti-m\u00fcllerian hormone cutoff for polycystic ovarian morphology in the diagnosis of polycystic ovary syndrome in the HARMONIA study: protocol for a prospective, noninterventional study","volume":"13","author":"TT Piltonen","year":"2024","journal-title":"JMIR Res Protoc"},{"issue":"5","key":"pone.0326162.ref032","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00125-012-2492-6","article-title":"Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention","volume":"55","author":"B Costa","year":"2012","journal-title":"Diabetologia"},{"issue":"2","key":"pone.0326162.ref033","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-012-2752-5","article-title":"Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)","volume":"56","author":"J Lindstr\u00f6m","year":"2013","journal-title":"Diabetologia"},{"key":"pone.0326162.ref034","author":"NHS England","year":"2021"},{"key":"pone.0326162.ref035","volume-title":"Unit costs of health and social care 2022 manual","author":"K Jones","year":"2022"},{"key":"pone.0326162.ref036","author":"National Health Service","year":"2024"},{"issue":"1","key":"pone.0326162.ref037","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.2021.131","article-title":"Healthcare resource use and costs for people with type 2 diabetes mellitus with and without severe mental illness in England: longitudinal matched-cohort study using the Clinical Practice Research Datalink","volume":"221","author":"H-I Wang","year":"2022","journal-title":"Br J Psychiatry"},{"issue":"1","key":"pone.0326162.ref038","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/2396987317746516","article-title":"The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke","volume":"3","author":"X-M Xu","year":"2018","journal-title":"Eur Stroke J"},{"key":"pone.0326162.ref039","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006"},{"issue":"8","key":"pone.0326162.ref040","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"R Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0326162.ref041","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cen.14726","article-title":"How to manage weight loss in women with obesity and PCOS seeking fertility?","volume":"97","author":"JM Hazlehurst","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"pone.0326162.ref042","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"AM Clark","year":"1995","journal-title":"Hum Reprod"},{"issue":"9","key":"pone.0326162.ref043","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet","volume":"18","author":"PG Crosignani","year":"2003","journal-title":"Hum Reprod"},{"key":"pone.0326162.ref044","volume-title":"International Evidence-based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome\u00a02023","author":"H Teede","year":"2023"},{"issue":"11","key":"pone.0326162.ref045","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3390\/nu11112611","article-title":"Prevention of type 2 diabetes by lifestyle changes: a systematic review and meta-analysis","volume":"11","author":"M Uusitupa","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"pone.0326162.ref046","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.semerg.2021.10.010","article-title":"Lifestyle interventions in women with polycystic ovary syndrome: a scoping systematic review of randomised evidence","volume":"48","author":"BH Al Wattar","year":"2022","journal-title":"Semergen"},{"key":"pone.0326162.ref047","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OAJC.S85543","article-title":"Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits","volume":"8","author":"AD de Melo","year":"2017","journal-title":"Open Access J Contracept"},{"issue":"1","key":"pone.0326162.ref048","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-21-0669","article-title":"Metabolic health during a randomized controlled lifestyle intervention in women with PCOS","volume":"186","author":"A Dietz de Loos","year":"2021","journal-title":"Eur J Endocrinol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:32:52Z","timestamp":1750167172000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326162"}},"subtitle":[],"editor":[{"given":"Sanaz","family":"Alaeejahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0326162","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}